Resistant oral mucosal lesions in pemphigus vulgaris responsive to double filtration plasmapheresis: First case report from Turkey

2013 ◽  
Vol 48 (2) ◽  
pp. 273-275 ◽  
Author(s):  
E. Şavk ◽  
M. Uslu ◽  
I. Yavaşoğlu ◽  
G. Kadıköylü ◽  
N. Şendur ◽  
...  
2020 ◽  
Vol 10 (21) ◽  
pp. 7404
Author(s):  
Roberto De Masi ◽  
Stefania Orlando ◽  
Salvatore Accoto

Double filtration plasmapheresis (DFPP) is an emerging semi-selective apheretic method for treating immuno-mediated neurological diseases. Here we report the first case of steroid-refractory relapsed multiple sclerosis (MS) on Fingolimod (FTY), treated effectively by this technique, in a 37-year-old woman. This condition is thought to be caused by soluble inflammatory species, but its demyelinating pattern is unknown; moreover, despite megadoses of intravenous 6-methyl prednisolone, it induces severe neurological deterioration, but dramatically responded to DFPP in our patient. The clinical improvement was driven by a strong DFPP-induced anti-inflammatory effect, with significant reduction of C3/C4 components, total gamma globulin concentrations (IgG), and gamma-fibrinogen (FGG), resulting in a brain pseudoatrophy phenomenon. Our findings are: first, the steroid-refractory relapsed MS on FTY, however serious, can be treated with DFPP; second, given the good clinical improvement due to the DFPP-induced neuroinflammatory components removal, this clinical condition can be associated with a Lucchinetti pattern II of demyelination.


2018 ◽  
Vol 51 (6) ◽  
pp. 379-385
Author(s):  
Kei Fukuda-Hihara ◽  
Masayuki Iyoda ◽  
Tomohiro Saito ◽  
Noriko Arai-Nunota ◽  
Yukihiro Wada ◽  
...  

1994 ◽  
Vol 27 (7) ◽  
pp. 1091-1094
Author(s):  
Yukihiko Matsuno ◽  
Hiroshi Oda ◽  
Hiroshige Ohashi ◽  
Yasunori Kotoo ◽  
Sachirou Watanabe ◽  
...  

2017 ◽  
Vol 5 (1) ◽  
Author(s):  
Arvind Babu Rajendra Santosh ◽  
Venkat Ramana Reddy Baddam ◽  
Chigurupati Anuradha ◽  
Chandrashekar Poosarla

Objective:To assess the prevalence of oral mucosal lesions in patients with pemphigus and pemphigoid diseases from Southern India. Design and Methods: A cross-sectional hospital based study was conducted from August 2010 to July 2011. Patients with confirmed pemphigus and pemphigoid skin disease were selected and informed to participate in the study. Oral examination of all participants were done to document site and type of oral manifestation and diagnostic procedures such as histopathological and Immunofluorescence methods were performed to confirm the diagnosis. Demographic details such as age, gender and occupation were also documented. The results of the study were analyzed by SPSS software version 19.0 (Armonk, NY) and presented as descriptive statistics. Results: Sixty percent of the patients exhibited oral mucosal manifestations. A higher female (86.66%) predilection of autoimmune blistering disease was observed in the study. A slightly higher number of pemphigoid patients (53.33%, 16 out of 30) were reported than pemphigus (46.66%, 14 out of 30 cases). The most common subtypes of pemphigus is Pemphigus vulgaris 71% (10 out of 14) among pemphigus, and bullous pemphigoid 87.5%(14 out of 16) among pemphigoid. Buccal mucosa (92.85%) is the most common site in pemphigus patients, where as hard palate (12.5%) is mostly commonly reported site in pemphigoid patients. Initial involvement of oral tissue in disease process was observed in 78.57% of pemphigus, and 12.5% of pemphigoid patients. Conclusion: Oral mucosal lesions are more frequently associated in pemphigus patients. Oral mucosal lesions are the initial site of disease process in pemphigus patients. The significance of diagnosis of oral lesions at earlier stage of disease, specifically pemphigus may help in early intervention of disease and help to reduce the morbidity and mortality state. The study emphasizes multidisciplinary approach in diagnosis and management of both pemphigus and pemphigoid.


2006 ◽  
Vol 52 (10) ◽  
pp. 556-559
Author(s):  
Miki ISHIBASHI ◽  
Kazuma NOGUCHI ◽  
Norio MASUDA ◽  
Kazunari SAKURAI ◽  
Masahiro URADE

2017 ◽  
Vol 21 (2) ◽  
pp. 119-122
Author(s):  
Athanasios Poulopoulos ◽  
Fotios Iordanidis ◽  
Dimitrios Andreadis ◽  
Konstantinos Antoniadis

SummaryBackground: Myeloid sarcoma (MS) is a solid malignant tumour associated with infiltration of immature myeloid precursor cells in an extramedullary site. The term MS has replaced the term granulocytic sarcoma and chloroma, which were used in the past. MS in the oral cavity is very uncommon, with less of 40 cases reported until recently. Case Report: We report the first case, the features, and the diagnostic sequence, of intraoral MS with bilateral palatal involvement, which presented as an initial manifestation, and preceded the appearance of acute myeloid leukaemia (AML). Diagnostic confirmation of such oral mucosal lesions usually requires biopsy, histopathological examination with additional immunohistochemical investigation. MS can occur during the course of acute or chronic myelogenous leukaemia, and myelodysplastic syndromes. In the vast majority of the reported cases, only one site was involved with a single intraoral MS lesion, and the cases predominantly associated with AML. Conclusion: The majority of intraoral MS occurs in patients with known AML, but in some of them, presented as an initial manifestation, and preceded the appearance of the disease. Therefore, clinicians should carefully evaluate all unusual oral lesions of unknown origin.


2003 ◽  
Vol 35 (1) ◽  
pp. 227-229 ◽  
Author(s):  
H Kawamura ◽  
M Matsumura ◽  
Y Kishi ◽  
K Fujikawa ◽  
K Uchiyama ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document